View all results
No results
News
Events
The industry
arrow_drop_down
Industry overview
Industrial biotech
Swiss Biotech Report
Success Stories
Company directory
Jobs
Networking platforms
Newsletter
Association
arrow_drop_down
Mission and services
Members
Academy
Partners
Team
Media
Add listing
Log in
or
Register
0
Add listing
Circadin® – prolonged release melatonin for insomnia is commercially available in Europe, Asia-Pacific, Latin America, Africa and the Middle East.
Product
prev
next
Leave a review
Bookmark
Share
Report
prev
next
Indicaton
Insomnia
Therapeutic indications
CNS
Neurology
Type of product
Small molecule
Company
Neurim Pharmaceuticals AG
Table
Phase
Marketed
You may also be interested in
3D CoSeedis in chip Assays
Preclinical 3D Study models for oncology and neurology.
Marketed
M4 PAM
Schizophrenia / Psychosis
Discovery
mGlu3 PAM for Neurodegenerative disorders
Neurodegenerative disorders
Discovery
Cart
×
View all results
No results
Facebook
Twitter
WhatsApp
Telegram
Pinterest
LinkedIn
Tumblr
VKontakte
Mail
Copy link
This site uses cookies:
Find out more.
Accept